Benjamin F. Edwards & Company’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $3.48M | Sell |
58,891
-6,576
| -10% | -$411K | 0.06% | 282 |
|
|
2024
Q1 | $5.22M | Sell |
65,467
-934
| -1% | -$71.3K | 0.09% | 207 |
|
|
2023
Q4 | $5.24M | Buy |
66,401
+4,476
| +7% | +$319K | 0.11% | 193 |
|
|
2023
Q3 | $4.32M | Buy |
61,925
+5,059
| +9% | +$358K | 0.17% | 117 |
|
|
2023
Q2 | $3.93M | Buy |
56,866
+3,482
| +7% | +$248K | 0.15% | 137 |
|
|
2023
Q1 | $3.97M | Buy |
53,384
+2,347
| +5% | +$197K | 0.17% | 131 |
|
|
2022
Q4 | $4.76M | Sell |
51,037
-2,927
| -5% | -$282K | 0.21% | 113 |
|
|
2022
Q3 | $5.15M | Sell |
53,964
-1,835
| -3% | -$182K | 0.26% | 92 |
|
|
2022
Q2 | $5.17M | Sell |
55,799
-217
| -0.4% | -$21.2K | 0.25% | 94 |
|
|
2022
Q1 | $5.67M | Sell |
56,016
-6,567
| -10% | -$690K | 0.25% | 96 |
|
|
2021
Q4 | $6.46M | Buy |
62,583
+551
| +0.9% | +$50.9K | 0.29% | 79 |
|
|
2021
Q3 | $5.26M | Sell |
62,032
-3,381
| -5% | -$283K | 0.26% | 86 |
|
|
2021
Q2 | $5.46M | Sell |
65,413
-2,194
| -3% | -$180K | 0.28% | 86 |
|
|
2021
Q1 | $5.09M | Sell |
67,607
-10,896
| -14% | -$794K | 0.27% | 84 |
|
|
2020
Q4 | $5.36M | Buy |
78,503
+12,988
| +20% | +$845K | 0.32% | 70 |
|
|
2020
Q3 | $3.83M | Buy |
65,515
+3,177
| +5% | +$198K | 0.26% | 92 |
|
|
2020
Q2 | $4.05M | Buy |
62,338
+4,190
| +7% | +$264K | 0.29% | 81 |
|
|
2020
Q1 | $3.45M | Buy |
58,148
+1,789
| +3% | +$119K | 0.29% | 87 |
|
|
2019
Q4 | $4.19M | Buy |
56,359
+4,537
| +9% | +$319K | 0.29% | 84 |
|
|
2019
Q3 | $3.27M | Buy |
51,822
+9,659
| +23% | +$572K | 0.26% | 100 |
|
|
2019
Q2 | $2.3M | Buy |
42,163
+7,039
| +20% | +$379K | 0.19% | 132 |
|
|
2019
Q1 | $1.89M | Buy |
35,124
+10,906
| +45% | +$673K | 0.17% | 138 |
|
|
2018
Q4 | $1.59M | Sell |
24,218
-14,363
| -37% | -$1.07M | 0.16% | 146 |
|
|
2018
Q3 | $3.04M | Buy |
38,581
+1,489
| +4% | +$106K | 0.29% | 81 |
|
|
2018
Q2 | $2.39M | Buy |
37,092
+8,540
| +30% | +$563K | 0.24% | 101 |
|
|
2018
Q1 | $1.78M | Buy |
28,552
+2,074
| +8% | +$149K | 0.18% | 130 |
|
|
2017
Q4 | $1.92M | Buy |
26,478
+19
| +0.1% | +$1.38K | 0.2% | 122 |
|
|
2017
Q3 | $2.15M | Buy |
26,459
+556
| +2% | +$44K | 0.26% | 93 |
|
|
2017
Q2 | $2.08M | Sell |
25,903
-5,111
| -16% | -$404K | 0.27% | 94 |
|
|
2017
Q1 | $2.44M | Buy |
31,014
+2,957
| +11% | +$236K | 0.36% | 69 |
|
|
2016
Q4 | $2.21M | Buy |
28,057
+6,440
| +30% | +$521K | 0.36% | 72 |
|
|
2016
Q3 | $1.92M | Buy |
21,617
+6,026
| +39% | +$569K | 0.34% | 69 |
|
|
2016
Q2 | $1.49M | Buy |
15,591
+819
| +6% | +$81.6K | 0.29% | 85 |
|
|
2016
Q1 | $1.53M | Buy |
14,772
+3,875
| +36% | +$377K | 0.32% | 74 |
|
|
2015
Q4 | $1.06M | Buy |
10,897
+5,857
| +116% | +$574K | 0.23% | 92 |
|
|
2015
Q3 | $486K | Buy |
5,040
+3,959
| +366% | +$416K | 0.11% | 186 |
|
|
2015
Q2 | $113K | Buy |
1,081
+421
| +64% | +$43K | 0.02% | 433 |
|
|
2015
Q1 | $68K | Hold |
660
| – | – | 0.01% | 510 |
|
|
2014
Q4 | $64K | Buy |
660
+55
| +9% | +$4.85K | 0.01% | 469 |
|
|
2014
Q3 | $48K | Buy |
605
+120
| +25% | +$9.46K | 0.01% | 512 |
|
|
2014
Q2 | $37K | Buy |
485
+235
| +94% | +$17.8K | 0.01% | 516 |
|
|
2014
Q1 | $19K | Hold |
250
| – | – | 0.01% | 586 |
|
|
2013
Q4 | $18K | Hold |
250
| – | – | 0.01% | 554 |
|
|
2013
Q3 | $14K | Hold |
250
| – | – | 0.01% | 560 |
|
|
2013
Q2 | $14K | Buy |
+250
| New | +$14.5K | 0.01% | 518 |
|
Other funds holding CVS
Benjamin F. Edwards & Company's CVS Position: Q2 2024 in Review
Benjamin F. Edwards & Company reduced its CVS Health (CVS) stake by 10% in Q2 2024, selling an estimated $411K and leaving 58,891 shares worth $3.48M. The position accounts for 0.06% of the portfolio, ranked #282.
Benjamin F. Edwards & Company first reported a position in CVS in Q2 2013 and has held it in 45 quarters since. The position peaked at $6.46M in Q4 2021. 1,911 funds tracked by Wall St. Rank hold CVS as of Q2 2024.
- Benjamin F. Edwards & Company held 58,891 shares of CVS Health worth $3.48M as of Q2 2024.
- Benjamin F. Edwards & Company sold 6,576 CVS Health shares in Q2 2024, an estimated $411K.
- CVS Health made up 0.06% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #282 holding.
- Benjamin F. Edwards & Company first reported a position in CVS Health in Q2 2013 and has held it in 45 quarters since.
- Benjamin F. Edwards & Company's CVS Health position peaked at $6.46M in Q4 2021.
- 1,911 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.
Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.